ILMN Live signaler | Maksimer profitt med Getagraph.com

KJøP 15 min ago

@ $104.97

Utstedt: 1 jul 2024 @ 16:44

Avkastning: 0.97%

Forrige signal: jul 1 - 15:36

Forrige signal: Selg

Avkastning: -0.63 %

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 16:59):
Our systems believe the stock currently is overvalued by -0.11% compare to its pairs and should correct downwards.

Stats
Dagens volum	524 836
Gjennomsnittsvolum	2.68M
Markedsverdi	16.88B
EPS	$-0.790 ( Q1 \| 2024-05-03 )
Neste inntjeningsdato	( $0.110 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.00 (Sector) 42.63 (Industry) 0
ATR14	$4.83 (4.56%)

ACRS 4.09%

AKU -17.87%

APDN 7.74%

BDSX -2.29%

BIOC 0.00%

BNGO -0.01%

BNR -3.02%

CDNA -0.19%

CEMI 0.22%

CHEK -1.51%

CNTG -1.53%

CSTL -2.99%

DMTK -11.32%

DRIO -1.68%

EXAS 1.14%

FLDM -7.02%

FLGT 0.56%

GENE -1.33%

GH -1.73%

GTH 0.12%

HTGM 0.00%

ICLR 1.88%

IDXX -1.25%

ILMN 1.54%

ISPC -2.91%

LAB -3.37%

LMDX 0.00%

MDXH -1.26%

ME -1.58%

MEDP 0.55%

MYGN -0.98%

MYNZ -14.94%

NDRA -3.09%

NEO 2.96%

NEOG -1.60%

NOTV -0.30%

NTRA -0.52%

OCDX 0.92%

OLK -0.04%

OPGN -3.10%

OPK -1.42%

PMD -3.31%

PRPO 4.85%

PSNL 0.43%

RDNT -0.03%

SERA 4.56%

SHC -1.77%

SQL 0.00%

STIM -1.09%

STRR -1.15%

STRRP -6.69%

SYNH 0.02%

TRIB 1.93%

TTOO 1.12%

TWST 3.12%

VIVO 0.00%

XGN -0.55%

Insider Trading

Date	Person	Action	Amount	type
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-05-16	Richo Anna	Buy	2 622	Common Stock

INSIDER POWER
83.86
Last 93 transactions
Buy: 263 719 \| Sell: 31 181

Korrelasjon (AI algo v.1.1b): Overvalued: -0.11% $106.03 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.56 (weak negative)

Kort: 0.97 (very strong)

Signal:(62) Expect same movement, but be aware

Illumina Inc Korrelasjon

10 Mest positive korrelasjoner
MBIO	0.894
APDN	0.878
SAGE	0.867
MPAA	0.865
JACK	0.865
VRSN	0.864
FAIL	0.864
INTZ	0.862
LSXMK	0.86
ASNS	0.86

10 Mest negative korrelasjoner
NKTR	-0.912
SMTC	-0.908
RVMD	-0.902
VERU	-0.901
AEYE	-0.9
USAP	-0.897
QRHC	-0.896
SGMA	-0.885
SLAM	-0.884
BNTC	-0.884

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Illumina Inc Korrelasjon - Valuta/Råvare

0.00
( neutral )

0.36
( neutral )

0.20
( neutral )

-0.26
( neutral )

0.08
( neutral )

0.56
( weak )

Illumina Inc Økonomi

Annual	2023
Omsetning:	$4.50B
Bruttogevinst:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2023
Omsetning:	$4.50B
Bruttogevinst:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2022
Omsetning:	$4.58B
Bruttogevinst:	$2.97B (64.83 %)
EPS:	$-28.05

FY	2021
Omsetning:	$4.53B
Bruttogevinst:	$3.15B (69.69 %)
EPS:	$5.07

Financial Reports:

No articles found.

Illumina Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Illumina Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.